Crossref
MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma
The Hematologist · 01.09.2026 · 23 (5)
DOI: 10.1182/hem.v23.5.202652 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Hematologist, online erschienen am 24.08.2026. Verfasst von Kwan-Keat Ang und 1 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ang, K., & Chari, A. (2026). MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma. The Hematologist, 23(5). https://doi.org/10.1182/hem.v23.5.202652
Vancouver
Ang K, Chari A. MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma. The Hematologist. 2026;23(5). doi:10.1182/hem.v23.5.202652
BibTeX
@article{Ang2026,
author = {Ang, Kwan-Keat and Chari, Ajai},
title = {MonumenTAL and MajesTEC Steps Forward in Bispecific Antibodies for Relapsed Refractory Multiple Myeloma},
journal = {The Hematologist},
year = {2026},
volume = {23},
number = {5},
doi = {10.1182/hem.v23.5.202652}
}
EUVIMED